223 related articles for article (PubMed ID: 6488418)
1. [Arboviruses and lemurs in Madagascar: experimental infection of Lemur fulvus with attenuated strains of yellow fever virus].
Rodhain F
Bull Soc Pathol Exot Filiales; 1984; 77(3):255-62. PubMed ID: 6488418
[TBL] [Abstract][Full Text] [Related]
2. Arboviruses and lemurs in Madagascar: experimental infection of Lemur fulvus with yellow fever and West Nile viruses.
Rodhain F; Petter JJ; Albignac R; Coulanges P; Hannoun C
Am J Trop Med Hyg; 1985 Jul; 34(4):816-22. PubMed ID: 2862804
[TBL] [Abstract][Full Text] [Related]
3. Arboviruses and lemurs in Madagascar: a preliminary note.
Rodhain F; Clerc Y; Albignac R; Ricklin B; Ranaivosata J; Coulanges P
Trans R Soc Trop Med Hyg; 1982; 76(2):227-31. PubMed ID: 6125046
[TBL] [Abstract][Full Text] [Related]
4. Arbovirus studies in Luanda, Angola. 1. Virological and serological studies during a yellow fever epidemic.
Pinto MR; Filipe AR
Bull World Health Organ; 1973; 49(1):31-5. PubMed ID: 4545154
[TBL] [Abstract][Full Text] [Related]
5. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
GROOT H
Bull World Health Organ; 1962; 27(6):709-15. PubMed ID: 13950709
[TBL] [Abstract][Full Text] [Related]
6. The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity.
Monath TP; Wilson DC; Casals J
Bull World Health Organ; 1973; 49(3):235-44. PubMed ID: 4546521
[TBL] [Abstract][Full Text] [Related]
7. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection.
Reinhardt B; Jaspert R; Niedrig M; Kostner C; L'age-Stehr J
J Med Virol; 1998 Oct; 56(2):159-67. PubMed ID: 9746073
[TBL] [Abstract][Full Text] [Related]
8. [Arboviroses in the region of Nosy-Bé, Madagascar. Serologic and entomologic data].
Fontenille D; Mathiot C; Rodhain F; Coulanges P
Bull Soc Pathol Exot Filiales; 1988; 81(1):58-70. PubMed ID: 2900082
[TBL] [Abstract][Full Text] [Related]
9. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
Adu FD; Adeniji JA; Tomori O; Adelasoye A
Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
[TBL] [Abstract][Full Text] [Related]
10. 1987 yellow fever epidemics in Oyo State, Nigeria: a survey for yellow fever virus haemagglutination inhibiting antibody in residents of two communities before and after the epidemics.
Olaleye OD; Omilabu SA; Faseru O; Fagbami AH
Virologie; 1988; 39(4):261-6. PubMed ID: 2851207
[TBL] [Abstract][Full Text] [Related]
11. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
[TBL] [Abstract][Full Text] [Related]
12. [Trial of experimental infection of Lemur fulvus fulvus by the influenza virus A/URSS/90/77(H1N1)].
Clerc Y; Ricklin B; Gueguen A; Coulanges P
Arch Inst Pasteur Madagascar; 1982; 49(1):43-63. PubMed ID: 6312909
[No Abstract] [Full Text] [Related]
13. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.
Poland JD; Calisher CH; Monath TP; Downs WG; Murphy K
Bull World Health Organ; 1981; 59(6):895-900. PubMed ID: 6978196
[TBL] [Abstract][Full Text] [Related]
14. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status.
Scott RM; Eckels KH; Bancroft WH; Summers PL; McCown JM; Anderson JH; Russell PK
J Infect Dis; 1983 Dec; 148(6):1055-60. PubMed ID: 6655288
[TBL] [Abstract][Full Text] [Related]
15. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate).
Price WH; Casals J; Thind I; O'Leary W
Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231
[No Abstract] [Full Text] [Related]
16. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.
Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD
Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107
[TBL] [Abstract][Full Text] [Related]
17. Arbovirus studies in Nupeko forest, a possible natural focus of yellow fever virus in Nigeria. I. Description of the area and serological survey of humans and other vertebrate hosts.
Monath TP; Lee VH; Wilson DC; Fagbami A; Tomori O
Trans R Soc Trop Med Hyg; 1974; 68(1):30-8. PubMed ID: 4206529
[No Abstract] [Full Text] [Related]
18. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas.
Monath TP; Craven RB; Muth DJ; Trautt CJ; Calisher CH; Fitzgerald SA
Am J Trop Med Hyg; 1980 Jul; 29(4):624-34. PubMed ID: 7406113
[TBL] [Abstract][Full Text] [Related]
19. TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER.
CAREY DE; MYERS RM; RODRIGUES FM
Am J Trop Med Hyg; 1965 May; 14():448-50. PubMed ID: 14292751
[No Abstract] [Full Text] [Related]
20. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.
GROOT H; RIBERIRO RB
Bull World Health Organ; 1962; 27(6):699-707. PubMed ID: 13950710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
